{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P12272",
      "entity_text" : "PTH-rP",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0088" ],
      "Organ" : [ "uberon:UBERON:0000104" ]
    }
  },
  "verbose_text" : "Production of PTH-rP is a common cause of hypercalcemia and is the most common paraneoplastic endocrine syndrome.31 About 80% of patients with malignancy associated hypercalcemia (MAH) have increased PTH-rP serum levels,32 and the high calcium levels are a result of the combined effects of PTH-rP on kidney and bone.",
  "reading_complete" : "2020-08-03T11:27:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:27:13Z",
  "trigger" : "levels",
  "evidence" : [ "PTH-rP serum levels" ],
  "pmc_id" : "6332744",
  "score" : 0
}